Evidence Hub

E053 Denosumab-induced hypocalcaemia in patients with low eGFR: a case series

Ridhwaana Jarmal, S. Donnelly, V. Ramasamy, Luke Williamson

Rheumatology, 2026

Abstract

There are limited therapeutic options for treating patients with severe osteoporosis and chronic kidney disease, especially those with an estimated glomerular filtration rate (eGFR) of < 30ml/min/1.732. These patients often have a very high risk of morbidity and mortality associated with a major osteoporotic fracture. Denosumab is effective at reducing the risk of osteoporotic fractures; however, it is associated with a risk of hypocalcaemia. We audited the risk of developing significant hypocalcaemia in patients with low eGFR taking denosumab for osteoporosis.

We present a small retrospective case series on patients with eGFR 50nmol/L). Blood monitoring of serum corrected calcium (cCa2+) was completed every 2 weeks for 6 weeks post denosumab injection (2, 4 and 6 weeks). All patients received high-dose Vitamin D3 as colecalciferol 20,000iu for 6 weeks (week 2, 4 and 6).

We terminated the audit after treating seven female patients (age 74-95 years). There were six Caucasian and one South Asian patient. Six patients had a history of multiple fractures and one patient had been taking letrozole. The median baseline eGFR was 24 (4-31) ml/min/1.732, and mean baseline serum cCa2 + (at time of 1st injection) was 2.44 mmol/l (2.22-2.65). At 2 weeks, the mean serum cCa2+ was 2.14 mmol/l (1.54-2.51), at week 4, 2.24 mmol/l (1.90.2.51) and at week 6, 2.25 mmol/l (1.94-1.41). Two out of seven patients developed severe hypocalcaemia in week 2 (1.54 mmol/l and 1.62 mmol/l) with emergency…

How strong is the evidence?

Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free